Growth Metrics

Halozyme Therapeutics (HALO) Goodwill & Intangibles (2022 - 2025)

Halozyme Therapeutics (HALO) has disclosed Goodwill & Intangibles for 4 consecutive years, with $1.6 billion as the latest value for Q4 2025.

  • Quarterly Goodwill & Intangibles rose 90.78% to $1.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 90.78% year-over-year, with the annual reading at $1.6 billion for FY2025, 90.78% up from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $1.6 billion at Halozyme Therapeutics, up from $765.4 million in the prior quarter.
  • The five-year high for Goodwill & Intangibles was $1.6 billion in Q4 2025, with the low at $765.4 million in Q3 2025.
  • Average Goodwill & Intangibles over 4 years is $949.5 million, with a median of $889.7 million recorded in 2023.
  • The sharpest move saw Goodwill & Intangibles dropped 21.08% in 2023, then surged 90.78% in 2025.
  • Over 4 years, Goodwill & Intangibles stood at $955.7 million in 2022, then decreased by 6.91% to $889.7 million in 2023, then fell by 7.99% to $818.7 million in 2024, then soared by 90.78% to $1.6 billion in 2025.
  • According to Business Quant data, Goodwill & Intangibles over the past three periods came in at $1.6 billion, $765.4 million, and $783.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.